Nanocarrier-Based Targeted Therapies for Myocardial Infarction
Myocardial infarction is a major cause of morbidity and mortality worldwide. Due to poor inherent regeneration of the adult mammalian myocardium and challenges with effective drug delivery, there has been little progress in regenerative therapies. Nanocarriers, including liposomes, nanoparticles, an...
| Published in: | Pharmaceutics |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-04-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/14/5/930 |